- Tytuł:
- Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth.
- Autorzy:
- Źródło:
- Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Jan 20; Vol. 42 (1), pp. 25. Date of Electronic Publication: 2023 Jan 20.
- Typ publikacji:
- Journal Article
- MeSH Terms:
-
Breast Neoplasms */drug therapyBreast Neoplasms */geneticsBreast Neoplasms */pathology
Humans ; Female ; Phosphatidylinositol 3-Kinases ; Cell Line, Tumor ; Choline/metabolism ; Choline/therapeutic use ; RNA, Small Interfering ; Receptor, ErbB-2/metabolism ; Drug Resistance, Neoplasm/genetics ; Phospholipases/genetics
Czasopismo naukowe